Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.37 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.34 |
| ▸ | APLNR | P35414 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | CPT2 | P23786 | 3/20 | 0.32 |
| ▸ | CPT1A | P50416 | 3/20 | 0.32 |
| ▸ | CPT1B | Q92523 | 3/20 | 0.32 |
| ▸ | RXRA | P19793 | 2/20 | 0.32 |
| ▸ | RXRB | P28702 | 2/20 | 0.32 |
| ▸ | RXRG | P48443 | 2/20 | 0.32 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.31 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.31 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23670689 | 0.93 | KDM4C (0.37) | KDM4CMRGPRX4APLNRKDM1ACPT2 | |
| SCHEMBL29554530 | 0.92 | ABL1 (0.36) | KDM4CKDM1ASCN9A | |
| SCHEMBL23669600 | 0.91 | KDM4C (0.40) | KDM4CMRGPRX4KDM1APTGDRPTGDR2 | |
| SCHEMBL23669554 | 0.87 | ABL1 (0.36) | KDM4CKDM1AGAAPPARGPPARD | |
| SCHEMBL29553798 | 0.87 | ABL1 (0.36) | KDM4CKDM1AGAAPPARGPPARD | |
| SCHEMBL23669556 | 0.87 | ABL1 (0.36) | KDM4CKDM1AGAAPPARGPPARD | |
| SCHEMBL23669537 | 0.87 | KDM4C (0.35) | KDM4CMRGPRX4APLNRCPT2CPT1A | |
| SCHEMBL23442624 | 0.85 | KDM1A (0.39) | KDM4CMRGPRX4KDM1ACPT2CPT1A | |
| SCHEMBL23669352 | 0.83 | KDM4C (0.35) | KDM4CMRGPRX4APLNRRXRAPTGDR | |
| SCHEMBL23688339 | 0.83 | KDM4E (0.34) | KDM4CKDM1AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210230189-A1 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | AMGEN INC. (US) | 2021-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210230189-A1 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | MCL1, BCL9, BCL2L1 | KDM4C 3483/4885MRGPRX4 3847/4885APLNR 3701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.